Sequestration-Related Cuts Affecting CDC’s TB Research Program

In a guest post in the Center for Global Health Policy’s “Science Speaks” blog, Coco Jervis, senior U.S. and global policy associate at the Treatment Action Group, examines how sequestration-related cuts are threatening the CDC’s Tuberculosis Trials Consortium, “the leading TB clinical research collaborative in the world,” she says. “Several TBTC sites have already been cut — and more may follow — hampering the TBTC’s ability to enroll patients into trials, narrowing the scope of research, and resulting in a loss of expertise,” she notes, adding, “Reaching the goal of zero TB deaths is well within our reach, but requires greater commitment by the Obama administration and Congress to support strong, sustained investment in new scientific advances to treat, diagnose, and prevent TB. Restoring funding for the TBTC is vital to stemming the TB epidemic and saving the lives of the millions affected by this disease” (6/27).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.